NONETHELESS, SIGNS OF PROGRESS
Despite the discouraging news from New York this week, there have been some small advances towards clinical applications of embryonic stem cells. Novacell, a small San Diego biotech, has developed a process which turns human embryonic stem cells into pancreatic cells which could cure diabetes. The company says that it hopes to begin animal tests in 2008 and human clinical trials in 2009. According to the New York Times, however, “such timeline projections by companies often prove overly optimistic”.
And at Johns Hopkins University in Baltimore, researchers have found that transplanting human embryonic stem cells into the spinal cords of rats bred to duplicate Lou Gehrig’s disease delays the start of nerve damage and slightly prolongs their lives. Their study was published in the journal Transplantation. The lead researcher cautioned that clinical applications are still distant.
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
A first in France: a trans mum and a trans dad
Trigger warning: if you are easily confused by gender pronouns, this story from France may cause heart palpitations. February 19...
Nigerian power couple convicted in London over organ trafficking plot
In May last year, a young Nigerian man stumbled into a police station into the English town of Staines, in...
Cease and desist: Dutch sperm donor who has fathered 550 children is being sued
A Dutch woman and a foundation for children of sperm donors are suing a Dutch man for fathering too many...
Should intractable mental illness make you eligible for euthanasia?
Canada is in the middle of a vigorous debate about whether incurable mental illness is grounds for Medical Assistance in...
Belgium to permit multiple gender ID changes
Belgium will permit people to change their gender identity as often as they want. The Minister of Justice, Vincent Van...
Nature’s foray into politics may have backfired
In the 2020 election, a swag of high-profile science journals, including Nature, Science, The Lancet, and the New England Journal...